BR0206870A - Método de modulação de resposta imune de um animal, e, suplemento dietético - Google Patents
Método de modulação de resposta imune de um animal, e, suplemento dietéticoInfo
- Publication number
- BR0206870A BR0206870A BR0206870-2A BR0206870A BR0206870A BR 0206870 A BR0206870 A BR 0206870A BR 0206870 A BR0206870 A BR 0206870A BR 0206870 A BR0206870 A BR 0206870A
- Authority
- BR
- Brazil
- Prior art keywords
- animal
- modulating
- dietary supplement
- immune response
- potentiation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/24—Animal feeding-stuffs from material of animal origin from blood
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Physiology (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
Abstract
"MéTODO DE MODULAçãO DE RESPOSTA IMUNE DE UM ANIMAL, E, SUPLEMENTO DIETéTICO Métodos e composições são descritos para a modulação do sistema imune de animais. O requerente identificou que a administração oral de imunoglobulinas purificadas de sangue animal pode modular IgG, TNF-A ou outros níveis de componentes de imunidade não especifica no soro para tratamento de distúrbios de disfunção imune, potenciação de protocolos de vacinação, e melhora de saúde geral e ganho de peso em animais, incluindo humanos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26498701P | 2001-01-30 | 2001-01-30 | |
US28406701P | 2001-04-16 | 2001-04-16 | |
US09/973,283 US20030103962A1 (en) | 2001-10-09 | 2001-10-09 | Methods and compositions for modulating the immune system of animals |
PCT/US2002/002752 WO2002078741A2 (en) | 2001-01-30 | 2002-01-29 | Methods and compositions for modulating the immune system of animals |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0206870A true BR0206870A (pt) | 2005-04-26 |
Family
ID=27401757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0206870-2A BR0206870A (pt) | 2001-01-30 | 2002-01-29 | Método de modulação de resposta imune de um animal, e, suplemento dietético |
Country Status (8)
Country | Link |
---|---|
US (4) | US20050271674A1 (pt) |
EP (1) | EP1357943A2 (pt) |
AU (1) | AU2002309486A1 (pt) |
BR (1) | BR0206870A (pt) |
CA (1) | CA2437095A1 (pt) |
MX (1) | MXPA03006818A (pt) |
PL (1) | PL214224B1 (pt) |
WO (1) | WO2002078741A2 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1357943A2 (en) * | 2001-01-30 | 2003-11-05 | The Lauridsen Group Incorporated | Methods and compositions for modulating the immune system of animals |
EP1357942A2 (en) * | 2001-01-30 | 2003-11-05 | The Lauridsen Group Incorporated | Methods and compositions for treatment of immune dysfunction disorders |
US20030190314A1 (en) * | 2001-01-30 | 2003-10-09 | The Lauridsen Group | Methods and compositions of treatment for modulating the immune system of animals |
WO2009143453A2 (en) * | 2008-05-23 | 2009-11-26 | The Lauridsen Group, Inc. | Methods and compositions for reducing lung inflammation in an animal |
CZ303161B6 (cs) * | 2009-02-26 | 2012-05-09 | Svus Pharma, A. S. | Zpusob biotechnologické výroby bovinního hemoderivátu |
ES2684130T3 (es) | 2009-04-09 | 2018-10-01 | Entegrion, Inc. | Productos de la sangre secados por aspersión y métodos para elaborar los mismos |
US8407912B2 (en) | 2010-09-16 | 2013-04-02 | Velico Medical, Inc. | Spray dried human plasma |
WO2011035062A2 (en) * | 2009-09-16 | 2011-03-24 | Velico Medical, Inc. | Spray dried human plasma |
US20140083628A1 (en) | 2012-09-27 | 2014-03-27 | Velico Medical, Inc. | Spray drier assembly for automated spray drying |
CA2816090A1 (en) | 2010-10-29 | 2012-05-03 | Velico Medical, Inc. | System and method for spray drying a liquid |
PL2606741T3 (pl) * | 2011-12-23 | 2014-08-29 | Foodip Sarl | Kompozycja wzbogacona w glikoproteinę jako dodatek do pokarmu i karmy i/lub jako środek terapeutyczny |
US9561184B2 (en) | 2014-09-19 | 2017-02-07 | Velico Medical, Inc. | Methods and systems for multi-stage drying of plasma |
US11975274B2 (en) | 2022-09-15 | 2024-05-07 | Velico Medical, Inc. | Blood plasma product |
US12083447B2 (en) | 2022-09-15 | 2024-09-10 | Velico Medical, Inc. | Alignment of a disposable for a spray drying plasma system |
US11998861B2 (en) | 2022-09-15 | 2024-06-04 | Velico Medical, Inc. | Usability of a disposable for a spray drying plasma system |
US11841189B1 (en) | 2022-09-15 | 2023-12-12 | Velico Medical, Inc. | Disposable for a spray drying system |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2607716A (en) * | 1949-08-02 | 1952-08-19 | Wisconsin Alumni Res Found | Prophylactic compositon for scours |
CA1046407A (en) * | 1975-06-20 | 1979-01-16 | Canada Packers Limited | Dried particulate animal serum of reduced saline content |
US4165370A (en) * | 1976-05-21 | 1979-08-21 | Coval M L | Injectable gamma globulin |
USRE33565E (en) * | 1978-02-06 | 1991-04-02 | Stolle Research And Development Corporation | Prevention and treatment of rheumatioid arthritis |
NL7900908A (nl) * | 1978-02-06 | 1979-08-08 | Slagteriernes Forskningsinst | Werkwijze ter bereiding van een materiaal op basis van bloed, alsmede de toepassing van het verkregen produkt als voedingsmiddel-toevoegsel. |
US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
SE448344B (sv) * | 1978-02-06 | 1987-02-16 | Stolle Res & Dev | Antikropp for behandling av reumatoid artrit samt sett att framstella denna |
US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
JPS6034997A (ja) * | 1983-05-09 | 1985-02-22 | ジヨージ、ジヨセフ、トダロ | 生物学的活性ポリペプチド類 |
CA1260828A (en) * | 1983-07-04 | 1989-09-26 | Masakazu Iwai | Therapeutic and prophylactic agent for gastrointestinal ulcers |
US4623541A (en) * | 1984-06-26 | 1986-11-18 | Candian Patents And Development Limited | Production of purified porcine immunoglobulins |
US4816252A (en) * | 1985-04-15 | 1989-03-28 | Protein Technology, Inc. | Product and process for transferring passive immunity to newborn domestic animals using ultrafiltered whey containing immunoglobulins |
US5093117A (en) * | 1989-01-24 | 1992-03-03 | Baxter International Inc. | Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
US5601823A (en) * | 1989-10-31 | 1997-02-11 | Ophidian Pharmaceuticals, Inc. | Avian antitoxins to clostridium difficle toxin A |
US5719267A (en) * | 1989-10-31 | 1998-02-17 | Ophidian Pharmaceuticals Inc. | Clostridial toxin disease therapy |
US5147639A (en) * | 1990-06-19 | 1992-09-15 | Ambico, Inc. | Type-c rotavirus cultures and uses therefor |
US5348867A (en) * | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
HUT71885A (en) * | 1992-07-08 | 1996-02-28 | Monsanto Co | Process for preparing a composition containing benzimidazoles for treatment stomach ulcer in swine |
US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US5681565A (en) * | 1993-01-12 | 1997-10-28 | Medical Sciences Research Institute | Methods and compositions for passive immunotherapy |
US5585098A (en) * | 1993-11-23 | 1996-12-17 | Ovimmune, Inc. | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants |
US5575999A (en) * | 1993-12-03 | 1996-11-19 | Ampc, Inc. | Animal feed supplement containing co-sprayed dried plasma protein and amylase |
US6090380A (en) * | 1994-01-12 | 2000-07-18 | Research Corporation Technologies, Inc. | Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin |
US5980953A (en) * | 1994-10-03 | 1999-11-09 | Stolle Milk Biologics, Inc. | Anti-inflammatory factor, method of isolation, and use |
US5531988A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Bacteria and immunoglobulin-containing composition for human gastrointestinal health |
US5531989A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
ES2142200B1 (es) * | 1995-08-01 | 2000-11-01 | Fichtel & Sachs Ag | Disco de embrague con un disco de friccion compuesto. |
DE19548221C1 (de) * | 1995-12-22 | 1997-05-15 | Biotest Pharma Gmbh | Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände |
ES2102971B1 (es) * | 1996-01-25 | 1998-03-01 | Hipra Lab Sa | Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. |
US5976537A (en) * | 1996-07-02 | 1999-11-02 | The United States Of America As Represented By The Secretary Of Agriculture | Porcine reproductive and respiratory syndrome vaccine |
KR20000048855A (ko) * | 1996-10-02 | 2000-07-25 | 오비뮨, 인크. | 닭의 난황 항체를 경구 투여하여 질병을 치료하는 방법 |
DK0835930T3 (da) * | 1996-10-09 | 2001-06-18 | Akzo Nobel Nv | Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV) |
US6004576A (en) * | 1997-08-11 | 1999-12-21 | Ampc, Inc. | Granular plasma protein supplement with increased bio-efficacy |
US6086878A (en) * | 1997-08-21 | 2000-07-11 | Dcv, Inc. | Method of increasing muscle protein and reducing fat in animals |
US20020114802A1 (en) * | 1998-02-10 | 2002-08-22 | Tjellstrom Bo Arthur Einar | Oral immunoglobulin treatment for inflammatory bowel disease |
US6258383B1 (en) * | 1998-08-14 | 2001-07-10 | Lactoferrin Products Company | Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format |
US20030190314A1 (en) * | 2001-01-30 | 2003-10-09 | The Lauridsen Group | Methods and compositions of treatment for modulating the immune system of animals |
EP1357943A2 (en) * | 2001-01-30 | 2003-11-05 | The Lauridsen Group Incorporated | Methods and compositions for modulating the immune system of animals |
-
2002
- 2002-01-29 EP EP02736484A patent/EP1357943A2/en not_active Withdrawn
- 2002-01-29 CA CA002437095A patent/CA2437095A1/en not_active Abandoned
- 2002-01-29 WO PCT/US2002/002752 patent/WO2002078741A2/en not_active Application Discontinuation
- 2002-01-29 PL PL373084A patent/PL214224B1/pl unknown
- 2002-01-29 MX MXPA03006818A patent/MXPA03006818A/es unknown
- 2002-01-29 AU AU2002309486A patent/AU2002309486A1/en not_active Abandoned
- 2002-01-29 US US10/470,982 patent/US20050271674A1/en not_active Abandoned
- 2002-01-29 BR BR0206870-2A patent/BR0206870A/pt not_active Application Discontinuation
-
2007
- 2007-10-29 US US11/926,419 patent/US20080138340A1/en not_active Abandoned
- 2007-10-29 US US11/926,442 patent/US20080213263A1/en not_active Abandoned
-
2012
- 2012-02-22 US US13/402,291 patent/US20120148570A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1357943A2 (en) | 2003-11-05 |
US20080213263A1 (en) | 2008-09-04 |
PL214224B1 (pl) | 2013-07-31 |
MXPA03006818A (es) | 2004-10-15 |
US20080138340A1 (en) | 2008-06-12 |
CA2437095A1 (en) | 2002-10-10 |
AU2002309486A8 (en) | 2005-10-13 |
PL373084A1 (en) | 2005-08-08 |
US20120148570A1 (en) | 2012-06-14 |
AU2002309486A1 (en) | 2002-10-15 |
WO2002078741A2 (en) | 2002-10-10 |
US20050271674A1 (en) | 2005-12-08 |
WO2002078741A3 (en) | 2003-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0206870A (pt) | Método de modulação de resposta imune de um animal, e, suplemento dietético | |
DK1599227T3 (da) | Fremgangsmåder til immunmodulation hos dyr | |
BR0206869A (pt) | método para o tratamento de um animal sofrendo de um estado doentio de disfunção imune associado com nìveis alterados de igg ou tnf-delta, composição farmacêutica para o tratamento de distúrbios auto-imunes associados com elevados igg e/ou tnf-delta ou para a potenciação de protocolos de vacina, e método para o tratamento de estado doentio associado com disfunção imune em um animal | |
ES2191103T3 (es) | Procedimientos de prevencion o de tratamiento de las alergias. | |
CY1110727T1 (el) | Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση | |
BR9203106A (pt) | Composicao alimentar,utilizacao e composicao parenterica | |
BR0211814A (pt) | Formulação contendo (liso-)fosfatidilserina para a prevenção e tratamento de estados de tensão em animais de sangue quente | |
BR9712259A (pt) | Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo. | |
WO2004025263A3 (en) | Protein and peptide expression for passive immunity | |
BR0314511A (pt) | Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater | |
BR0312683A (pt) | Cápsulas de higiene oral | |
BRPI0314666B8 (pt) | composição nutricional ou terapêutica utilizável para o tratamento de mamíferos para aumentar a atividade imune | |
ITMI911791A1 (it) | Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari. | |
BR0210648A (pt) | Variante de uma molécula imunointerativa, anticorpo monoclonal, forma disimunizada de anticorpo monoclonal 3b6, método para a geração de um anticorpo monoclonal desimunizado, molécula de anticorpo desimunizada, anticorpo desimunizado, anticorpo monoclonal de murino variante 3b6 desimunizado, variante de um anticorpo monoclonal de murino 3b6 desimunizado para uso em humanos, método para a detecção de um coágulo sanguìneo em um paciente humano, método para a detecção de um coágulo sanguìneo ou de um seu fragmento de ligação a antìgeno, método para a facilitação da dissolução ou da remoção de um coágulo sanguìneo em um humano, uso de um anticorpo monoclonal derivado de murino variante, e, conjugado | |
WO2002020619A3 (en) | HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) | |
WO2004014461A3 (en) | Device for administration of fluids | |
DE69527713D1 (de) | Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung | |
BR9608392A (pt) | Preparação multiparticulada de liberação controlada e forma de dosagem em tablete. | |
WO2005056601A3 (en) | Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse? | |
BR0112296A (pt) | Composição consistindo de ou contendo pelo menos um soro de leite dissimilado | |
DK0852623T3 (da) | Nukleinsyremolekyler kodende for proteiner, som medierer adhæsionen af Neisseria-celler til humane celler | |
ATE458004T1 (de) | Osteoprotegerin in milch | |
BR0317895A (pt) | Método de melhora da circulação sanguìnea | |
GB2358352A (en) | Bacterial extract as oral adjuvant | |
RU94033173A (ru) | Способ повышения репродуктивной функции мужчин |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |